The present model of G protein activation by G protein-coupled receptors exclusively localizes their activation and function to the plasma membrane (PM). Observation of the spatiotemporal response of G protein subunits in a living cell to receptor activation showed that 6 of the 12 members of the G protein ␥ subunit family translocate specifically from the PM to endomembranes. The ␥ subunits translocate as ␤␥ complexes, whereas the ␣ subunit is retained on the PM. Depending on the ␥ subunit, translocation occurs predominantly to the Golgi complex or the endoplasmic reticulum. The rate of translocation also varies with the ␥ subunit type. Different ␥ subunits, thus, confer distinct spatiotemporal properties to translocation. A striking relationship exists between the amino acid sequences of various ␥ subunits and their translocation properties. 
GPCR
2 stimulation results in the activation of G protein ␣ and ␤␥ subunit complexes which modulate the function of downstream effector molecules that function on the cytosolic surface of the PM (1-4). The classic model of GPCR action, thus, restricts the activation of G proteins and consequently their effectors to the two-dimensional plane of the PM (1) (2) (3) (4) . Intracellular effects have been thought to occur through second messengers released through the activation of effector molecules such adenylyl cyclase, phospholipase C␤, and ion-conducting channels. Direct communication of a GPCR with intracellular membranes through the G protein subunits has not been anticipated. We have used live cell imaging methods to examine the spatiotemporal dynamics of the localization of components of a GPCR-mediated signaling pathway when the pathway is activated and deactivated.
In mammalian cells similar to GPCRs the G protein subunits are also families of proteins. Based on the presence of distinct genes, there are 16 ␣ subunits, 5 ␤ subunit, and 12 ␥ subunit types. The ␣ subunit types appear to possess distinctly different properties (3, 4) . Although evidence exists for the differential activity of ␤␥ subunit types in terms of their role in receptor activation of a G protein and modulation of effector function, these differences have been subtle and quantitative (5) (6) (7) (8) (9) (10) (11) (12) . One potential reason for a lack of evidence for qualitative differences in the properties of these diverse proteins is that most assays used so far to measure G protein function have used techniques that lead to disruption of cells. The possibility that these proteins are involved in spatially distinct functions has, thus, remained unexplored.
Here we examined the entire family of ␥ subunit types complexed with different ␤ subunit types for potential translocation in response to GPCR activation in various cell lines. There have been previous indications from our laboratory that the ␤ 1 ␥ 11 and ␤ 1 ␥ 5 subunit complexes translocate away from the PM on receptor activation (13) . To identify the mechanistic basis, the translocation properties were examined in the presence of inhibitors of vesicle-mediated trafficking, an acylation inhibitor, and after introducing mutations into the ␥ subunit C-terminal domain previously shown to interact with receptors (14) . We identified potential ␤␥ complexes capable of translocation in a live cell by examining fluorescence resonance energy transfer (FRET) between fluorescent protein-tagged subunits. We examined the impact of cell lines of different origins and various ␣ subunit types and receptors on the translocation of ␤␥ complexes. Although it has been known that a large and diverse family of ␥ subunits with highly conserved structures exists (12, 15, 16) , striking differences in their signaling properties have not been found. Results here show that the ␥ subunits control the spatiotemporally distinct translocation of a large variety of ␤␥ complexes from the PM to endomembranes, thus making it * This work was supported by National Institutes of Health Grant GM 69027 and an American Heart Association post-doctoral fellowship (to M. C.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact. possible for GPCRs on the cell surface to direct an active component of a G protein to intracellular membranes.
MATERIALS AND METHODS
Chemicals and Expression Constructs-All chemicals were purchased from Sigma unless otherwise indicated. ␣ o -cyan fluorescent protein (CFP), yellow fluorescent protein (YFP)-␤ 1 and CFP-or YFP-tagged ␥ 5 and ␥ 11 constructs have been described previously (13) . The citrine mutant of YFP and the non-oligomerizing forms of both CFP and YFP (17) were engineered by mutagenesis and used in all experiments. The ␥ 1 , ␥ 2 , ␥ 3 , ␥ 4 , ␥ 7 , ␥ 8 (␥ olf ), ␥ 9 (␥ cone ), ␥ 10 , ␥ 12 , ␥ 13 , ␤ 1 , ␤ 2 , ␤ 3 , and ␤ 4 cDNAs were introduced downstream of YFP or mCherry (18) (from R. Tsien) in the pCDNA 3.1 or pDest vectors (Invitrogen). All constructs were checked by determining the nucleotide sequence. Red fluorescent protein DsRed2-KDEL marker and DsRed monomer galactosyl transferase (Clontech). Transferrin-Texas Red was from Molecular Probes.
Cells and Transfection-Native CHO cells and those stably expressing the M2 muscarinic receptor (M2-CHO) (19) and the M3 muscarinic receptor (M3-CHO) (20) have been described previously. CHO cells were grown in CHO IIIa medium (Invitrogen) containing dialyzed fetal bovine serum (Atlanta Biologicals), methotrexate (for M2-CHO, M3-CHO), penicillin, streptomycin, glutamine, and Fungizone. HeLa and J774.1 cell lines were obtained from American Type Culture Collection and were grown in specific media recommended by the ATCC. All the transfections were performed using Lipofectamine 2000 (Invitrogen). M2-CHO cells stably expressing ␣ o -CFP, ␤ 1 , and YFP-␥ 11 were generated using standard procedures, screened with flow cytometry, and cultured in CHO-IIIa medium containing methotrexate and Geneticin (G418).
Treatment of Cells-To disrupt Golgi in the cells, 10 M brefeldin A was used in the culture medium 6 -10 h before cell imaging. For treatment with nocodazole, transfected or stable cells were cooled on ice for 5 min, then nocodazole (5 g/ml) was added, and cells were further incubated for 15 min on ice followed by incubation at 37°C for 5 min. As a control, 5 g/ml transferrin-Texas Red conjugate was then added to the cells for 15 min at 37°C after which the cells were visualized to monitor vesicular trafficking. The imaging was done in the presence of nocodazole. For monensin treatment the cells were treated with 50 M monensin for 1 h at 37°C before imaging. For cycloheximide treatment the cells were treated with 50 g/ml cycloheximide for 6 -8 h at 37°C before imaging. For treatment with 2-bromopalmitate (2BP), the media was removed from the cells, and fresh Hanks' buffer saline solution containing 50 M 2BP (stock prepared in Me 2 SO (21)) was added to the cells, and the cells were incubated for a further 30 min at 37°C before imaging.
Imaging of Live Cells-Cells were cultured on acid-washed glass coverslips and transiently transfected with appropriate combinations of different G protein subunits and GPCRs as described in the text and figure legends. After 16 -24 h posttransfection the cells were processed for imaging as follows. The coverslips were washed with Hanks' buffer saline solution supplemented with 10 mM HEPES, pH 7.4, and mounted on an imaging chamber with an internal volume of 25 l (RC-30 chamber, Warner Instruments). For live cell imaging, a fluid delivery system including a programmable valve controller and Teflon valves (10-ms open/closure time) (Automate Scientific) was used to deliver the buffer with or without agonist or antagonist through the chamber at a rate of 0.5 ml/min with a regulated flow controller. The cells were visualized with a Zeiss Axioskop fluorescent microscope using a 63ϫ oil immersion objective (1.4 NA) and 100-watt mercury lamp with a Hamamatsu CCD Orca-ER camera. The shutter and emission and excitation filter wheels were controlled by a Sutter Lambda 10 -2 optical filter changer (Sutter Instrument Co.) run by MetaMorph 6.3.7 (Molecular Devices) software. The filter and beam splitter combinations (Chroma Technology) were as follows; for CFP, D436/10 excitation, D470/30 emission; for YFP, D500/20 excitation, D535/30 emission; for mCherry or DsRed D580/20 excitation, D630/60 emission, a polychroic beam splitter (Chroma 86002BS) and 25 or 10% neutral density filters. In those cases where both CFP and YFP fusions were co-expressed in cells, the cells expressing relatively similar levels of the two fusions were selected based on emission intensities. Images were acquired at 20-or 10-s intervals, and the exposure times were between 0.1 and 1.0 s. Details of the FRET analysis are described in Chisari et al. (66) . FRET analysis was performed not only with YFP-and CFP-tagged proteins but also mCherry (mCh) and YFP combinations as described. Details of the experiments performed with confocal microscopy are provided in Chisari et al. (66) .
RESULTS
Receptor Induced ␤␥ Subunit Translocation-G protein signaling has been thought to be exclusively localized to the PM with heterotrimers being activated by transmembrane receptors and the activated subunits acting on PM-associated effectors. We used CHO cells stably expressing M2 receptors (M2-CHO) transiently transfected with ␣ o , ␤ 1 , and different ␥ subunits tagged with YFP to evaluate the effect of receptor activation on various G protein ␥ subunits. We have previously demonstrated that ␤ and ␥ subunits with an N-terminal fluorescent protein fusion localize normally on the PM and support normal activation of the G protein by a receptor (22) . Images of the cells were captured at defined intervals of time, whereas they were sequentially exposed first to a muscarinic receptor agonist, carbachol, and then to an antagonist, atropine. Emission intensities from the intracellular membranes were plotted as a function of time to quantitate potential translocation of the fluorescent protein-tagged ␥ subunit. The ␥ subunits which translocated were initially clearly localized to the PM (Fig. 1) . When various members of the ␥ subunit family were examined, it was observed that six different ␥ subunit types translocated to specific intracellular membranes in a receptor-mediated manner. On antagonist addition they translocated back to the PM. The ␥ 1 , ␥ 5 , ␥ 9 , and ␥ 10 translocated to a focused intracellular region, which was similar to the cellular localization of the translocated ␥ 11 subunit previously reported (13) (Fig. 1A , top panel, Fig. 1B , and supplemental Figs. 1 and 2). In striking contrast, the ␥ 13 subunit translocated to endomembranes with a more diffuse spatial distribution (Fig. 1C, top panel) . Corresponding to the changes in endomembrane fluorescence inten-sity in response to the agonist and antagonist, corresponding changes in the opposing direction were observed in the PM (supplemental Fig. 3 ). In addition, a plot of the intensity of the Golgi marker, galactosyl transferase-DsRed, after exposure to agonist and antagonist did not show significant changes like the intensity plot for YFP-␥9 (supplemental Fig. 4 ). These results confirmed that the increase in endomembrane fluorescence intensity is not due to a change in Golgi size or shape.
The G protein ␥ subunits are modified with a prenyl moiety. ␥ 1 , ␥ 9 , and ␥ 11 are farnesylated, whereas all other ␥ subunits are geranylgeranylated (23) . The translocation process by itself is not dependent on the type of prenyl moiety attached to a ␥ subunit type because ␥ 5 , ␥ 10 , and ␥ 13 are capable of translocation, although they are geranylgeranylated.
Endomembranes as Target Membranes for Translocating ␤␥ Complexes-To identify the membranes to which the ␥ 9 and ␥ 13 subunits translocate, markers tagged with fluorescent proteins specific to the Golgi and the ER were used. A trans-Golgi marker, galactosyl transferase-tagged with monomeric DsRed (24, 25) and YFP-␥ 9 were coexpressed in M2-CHO cells and imaged in a confocal microscope after M2 activation. Overlaying the images of galactosyl transferase-DsRed monomer and YFP-␥ 9 showed that YFP-␥ 9 localized specifically to the endomembranes (predominantly Golgi complex) after translocation (Fig. 1A, bottom panel) . To further confirm this localization, we treated the transfected M2-CHO cells with brefeldin A, which is known to disrupt the Golgi complex (26) . When these cells were examined after agonist treatment, translocation of YFP-␥ 9 to the Golgi region could no longer be detected (not shown). These results indicated that ␥ 9 translocates primarily to the Golgi region.
To identify the membranes to which the G protein ␤ 1 ␥ 13 complex translocated, we coexpressed the ER retention KDEL sequence of calreticulin, a specific marker for the ER tagged with DsRed (27-29) with YFP-␥ 13 in M2-CHO cells and imaged the cells after M2 activation. To examine whether ␥ 13 translocates to the Golgi also apart from the ER, we treated the transfected M2-CHO cells with brefeldin A. On agonist addition ␥ 13 translocated to endomembranes. Overlaying the images of KDEL-DsRed and translocated YFP-␥ 13 showed that YFP-␥ 13 was localized to the ER (Fig. 1C, bottom panel) . When antagonist was added, ␥ 13 reverse-translocated back to the PM. The ␥ 13 subunit was initially localized to the PM and ER (Fig. 1C, top  panel) . When cells expressing ␥10 were similarly examined with a Golgi marker, the target of the translocation was predominantly the Golgi complex (not shown).
We examined whether reverse translocation on the addition of an antagonist subsequent to agonist addition was due to an effect independent of the receptor. Instead of antagonist addition, agonist was withdrawn by introducing buffer. The ␥ 9 , ␥ 11 , and ␥ 13 subunits reverse-translocated in these cells, similar to the cells treated with antagonist, although the t1 ⁄ 2 for reversal was comparatively slower (not shown). The slower kinetics would be anticipated because the antagonist would be able to shift the receptor to its inactive state more rapidly by displacing agonist binding directly. This experiment indicated that reverse translocation is the outcome of switching the activated state of the receptor to its inactive state.
Subfamilies of ␥ Subunits with Distinct Kinetics of Translocation-We measured the rate of translocation of the various ␥ subunits by measuring the proportion of the fluorescent protein-tagged ␥ subunit that translocated from PM to intracellular membranes at various time points. When the rate of translocation of the different ␥ subunits was compared, distinct differences were seen. ␥ 10 and ␥ 5 translocated relatively slowly (t1 ⁄ 2 ϳ 39 -85 s) (Fig. 1B, plot, and supplemental Fig. 2) , whereas the other subunits, ␥ 1 , ␥ 9 , ␥ 11 , and ␥ 13 , translocated rapidly (t1 ⁄ 2 ϳ 6 -13 s) (Fig. 1, A and C, supplemental Fig. 1) . To examine the relationship between the translocating and nontranslocating ␥ subunits, the human ␥ subunit amino acid sequences were aligned and analyzed for their evolutionary relationship. The resulting phylogenetic tree shows that the ␥ subunits that translocate in a receptor induced fashion, ␥ 1 , ␥ 5 , ␥ 9 , ␥ 10 , ␥ 11 , and ␥ 13 , show a strikingly closer relationship to each other compared with other ␥ subunits (Fig. 1D and Fig. 2A) . The two classes of ␥ subunit types based on the rate of translocation, relatively slow and rapid, also show a closer relationship within a subfamily (Fig. 1D) . Furthermore, ␥ 13 is distinct compared with the other rapidly translocating ␥ subunits. These results suggest that translocation is dependent on the amino acid sequences of the ␥ subunits. This is an inference that is consistent with the nature of the prenyl moiety not having any discernible effect on translocation (below). The differential translocations of the ␤␥ complexes are, thus, both qualitative and quantitative. Such differences in the properties of G protein ␤␥ subunits have not been noted before.
The G Protein ␥ Subunit Mediates Translocation of a ␤␥ Complex-The ␣ subunit types, ␣ o , ␣i, or ␣ q , coexpressed with a translocating ␥ subunit did not translocate (supplemental Fig.  5A ). This result suggested that translocation is restricted to the ␤␥ complex because the ␥ subunit is known to be tightly bound to the ␤ subunit (12, 15, 16) . To confirm that the ␥ subunits translocate as ␤␥ complexes, untagged ␥ subunits were expressed with the ␤ 1 subunit tagged with YFP or mCh (18) in M2-CHO cells. In the presence of agonist, translocation of the YFP-␤ 1 or mCh protein was observed (supplemental Fig. 5B ). This result confirmed (i) ␥ subunit translocation occurs as a ␤␥ complex, (ii) that the translocation process is directly influenced only by the type of ␥ subunit, and (iii) the ␥ subunit fluorescent protein tag does not have an effect on the translocation. To rule out the possibility that ␤ subunit translocation is a result of interaction with a cellular protein other than the ␥ subunit, which is capable of translocation, we evaluated receptor-mediated translocation in M2-CHO cells transfected with the fluorescent protein-tagged ␤ 1 subunit without a translocating ␥ subunit. In such cells significant translocation of the ␤ 1 subunit was not detected on receptor activation (data not shown). This result indicated that the ␥ subunits directly mediate translocation of the ␤␥ complex. Furthermore, YFP or mCh-␤ 1 not only cotranslocated with CFP-or YFP-tagged translocation-competent ␥ subunits, but more important, acceptor (YFP or mCh) photobleaching indicated measurable FRET between YFP or mCh-␤ 1 and CFP or YFP-␥ subunits as described below. These results confirm that translocation occurs as a ␤␥ complex.
Mutation of Residues at the C-terminal Domain of a Nontranslocating Subunit Results in the Gain of Translocating
Ability-The ability of the G protein ␥ subunit to influence receptor-mediated translocation was reminiscent of the role of the ␥ subunit in receptor interaction of a G protein that we first showed in the rhodopsin-transducin system and later with ligand binding receptors (5, 6, 19, 30) . It raised the possibility that receptor contact with the ␥ subunit is a critical mediator of translocation. Previous evidence from the rhodopsin and muscarinic receptor systems has suggested that an 11 amino acid domain at the C terminus of the processed ␥ subunit contacts receptors (19, 30 -33) . Two-dimensional NMR has shown that a peptide encompassing this domain directly interacts with activated but not inactive rhodopsin (14, 34) . To examine this possibility we compared the amino acid sequences of the human ␥ subunits. Fig. 2A shows an alignment of the ␥ subunit primary structures. In Fig. 2A residues in this C-terminal domain conserved within the subfamily of subunits that translocate rapidly and the subfamily of subunits that do not translocate are highlighted. The conservation of these residues within the subfamilies with distinct translocation properties suggested that they may play a role in regulating translocation. We examined a hypothesis that the affinity of this C-terminal domain of a ␥ subunit for a receptor determines whether it will translocate. To examine whether conserved residues that are strikingly different between the non-translocating and translocating subunits played a role in the translocation, we mutated five residues in the ␥ 3 subunit that does not translocate (Fig. 2B) . The ␥ 3 mutant was expressed in M2-CHO cells, and receptor-induced translocation was examined. Results in Fig. 2B show that the ␥ 3 mutant has gained the ability to translocate due to the alterations in the C-terminal domain. This result shows that C-terminal residues of the ␥ subunit are critical for translocation, consistent with a model that non-translocating ␥ subunits have a high affinity for the activated receptor, whereas translocating ␥ subunits have distinctly lower affinity (32) . 13 is targeted predominantly to the ER, unlike ␥ 1 , ␥ 9 , and ␥ 11 , which are targeted to the Golgi, although they also translocate relatively rapidly. We examined whether the C-terminal domains of the G protein ␥ subunits are involved in the differential targeting of the translocating ␥ subunit types. Because this domain is also post-translationally modified with different prenyl moieties (farnesyl or geranylgeranyl), these experiments also examined whether the prenyl moiety influences differential targeting. The C-terminal 14 residues of ␥ 9 were substituted with the corresponding sequence of the ␥ 13 subunit (Fig. 2, A  and C) . This domain has been shown to be involved in receptor interaction previously (14, 19, 30, 31) . Although ␥ 9 is farnesylated, the C-terminal residues of ␥ 13 (-CTIL; Fig. 3A) will ensure that the chimera is geranylgeranylated in the cell as demonstrated before for such ␥ subunit mutants using high performance liquid chromatograph separation and mass spectrometry (35, 36) . When the YFP-␥ 9 -␥ 13 chimera was expressed in M2-CHO cells and its receptor-mediated translocation was examined, it translocated predominantly to the Golgi complex (Fig. 2C) . In a similar experiment, a YFP-␥ 13 chimera made up of the C-terminal 14 residues of ␥ 9 which will be farnesylated, was targeted predominantly to the ER (Fig. 2C) . These results indicated that the targeting of the ␥ subunits to different membranes is not influenced by the C-terminal domain of the ␥ subunit. The results also show that the prenyl moiety does not play a role in the differential targeting.
Translocation to Different Endomembranes Is Not Dependent on the C-terminal Domain of the ␥ Subunit or the Type of Prenyl Moiety-␥
Effect of Different ␣ Subunit Types, Receptors, and Cell Types on Translocation-The ␣ subunits of G proteins are the most diverse among the G protein subunit families and are known to be specific in their interaction with GPCRs (4). To evaluate the effect of different ␣ subunits on receptor-mediated translocation of ␤␥ complexes, we examined translocation in the pres- ence of ␣ q , which couples with M3 receptors (20) . M3-CHO cells showed receptor-induced translocation of different ␥ subunits (Fig. 3) . Similarly different GPCRs also induced ␤␥ translocation (Fig. 4) . Translocation occurred in a variety of cell lines (Fig. 5, A and B) . ␥ 9 and ␥ 11 translocation was also detected in COS 7 cells, and ␥ 11 was detected in human lung epithelial cells (not shown). These results showed that receptor-induced ␤␥ translocation is a general phenomenon. We then examined whether receptors endogenous to a cell induce translocation of ␥ 13 , which is targeted to the ER. ␣2-adrenergic receptors endogenous to HeLa cells (11) induced the translocation of ␤ 1 ␥ 13 complexes (Fig. 5C) , and hence, translocation is not a consequence of heterologous expression of a receptor.
Identification of the ␤␥ Complexes Capable of Translocation in a Live
Cell-To identify the ␤ subunit types capable of forming a complex with the translocating ␥ subunits in a live cell, we used two approaches. We examined the cotranslocation of YFP or mCh-␤ subunit types in the presence of various translocating ␥ subunit types tagged with YFP or CFP. Secondly, we examined FRET between the various members of the translocating family of ␥ subunits and the four members of the ␤ subunit family known to function as complexes with ␥ subunits. mChor YFP-tagged ␤ subunits were used as acceptors, and YFP-or CFP-tagged ␥ subunits were used as donors. Acceptor photobleaching experiments were used to examine for the presence of a FRET signal as we and others have done (22, (37) (38) (39) . We obtained a measurable FRET signal between some combinations of ␤ and ␥ subunits but not all, indicating which combinations bound effectively with each other (supplemental Fig. 6 and Table 1 ). The cotranslocation of mCh-␤ subunit types was completely consistent with the results of the FRET experiments; only those ␥ subunits that provided FRET with a ␤ subunit type induced co-translocation of that ␤ subunit type. Together these experiments showed that ␤ 1 and ␤ 3 subunits form a complex with all the translocating ␥ subunits, whereas ␤ 2 and ␤ 4 form a complex with only ␥ 5 , ␥ 9 , and ␥ 13 subunits (Table 1 ). We and others have shown selective association of G protein ␤ and ␥ subunit types, and these results both emphasize such selectivity and also expand the examination of association between members of these families to the entire family of potential ␤␥ complexes (40 -44) . Furthermore, the results show that even if a cell contains ␥ subunits that are capable of translocating, translocation of a ␤␥ complex can occur only if the appropriate ␤ subunit is expressed in that cell.
Translocation Process Is Controlled by Acylation and Is Likely Diffusion-mediated-Evaluation of the kinetics of translocation and reverse translocation of ␥ 1 , ␥ 9 , ␥ 11 , and ␥ 13 indicated that these subunits respond swiftly to both receptor-dependent agonist activation and antagonist inactivation as shown above ( Fig.  1 and supplemental Fig. 1 ). This rapidity of translocation in both directions suggested that the translocation process is most likely diffusion-mediated. To examine whether the translocation was vesicle-mediated or diffusive, we observed the receptor-induced translocation of the ␥ 11 subunit at 16°C. At this temperature, vesicle-mediated transport is inhibited completely (45) . Translocation induced by M2 receptor activation was unaffected by lowering the temperature (data not shown), indicating that the translocation is most likely diffusion-mediated. To further confirm that the translocation is independent of vesicle-mediated trafficking, translocation of YFP-␥ 11 was examined in M2-CHO cells after treating them with a microtubule disrupting agent, nocodazole, which blocks vesicular trafficking occurring through Golgi, and also monensin, which blocks the trafficking of proteins from the Golgi to PM (26) . Each of these treatments did not have an effect on ␤␥ translo- cation, confirming the earlier observation that the translocation process is most likely diffusion-mediated (not shown). Receptor-mediated translocation of the ␤␥ subunits was also unaffected by inhibition of protein synthesis with cycloheximide (not shown). This result showed that the translocation process does not require newly synthesized proteins. Furthermore, we observed antagonist-mediated reverse translocation of ␤␥ in the presence of monensin, showing that receptor-governed reverse translocation of the ␤␥ complex to the PM is independent of forward vesicular trafficking of proteins from Golgi to PM. Although the trafficking pathway that determines G protein localization on the PM originating from the Golgi has been shown to be both vesicle-mediated and non-vesicle-mediated (46, 47) , the results here show that, similar to forward translocation, reverse translocation is also likely to be entirely diffusion-mediated. These findings are consistent with a prediction that translocating membrane-binding proteins are likely to move rapidly back and forth through the cytosol diffusively (48) .
We determined that shuttling of G protein subunits between the PM and endomembranes is likely regulated by an acylation/deacylation cycle because it is inhibited by 2BP (66), a well characterized inhibitor of palmitoyl transferases (49) . When M2-CHO cells stably expressing ␣ o -CFP, ␤ 1 , and YFP-␥ 11 were exposed to 2BP and receptorinduced translocation was examined, translocation was significantly inhibited in most cells (Fig. 6 ). In addition, 2BP inhibited ␤␥ 11 translocation by a different receptor, M3, in cells coexpressing ␣ q (not shown). A FRET signal was detected in the PM of the cells stably expressing ␣ o -CFP, ␤ 1 , and YFP-␥ 11 , and FRET was abrogated on receptor activation with an agonist showing that the G protein present on the PM in 2BP-treated cells was capable of getting activated (66) . This result showed that activation of the G protein is not sufficient for translocation and an acylation dependent mechanism underlies this process.
DISCUSSION
Overall these results indicate that free ␤␥ subunits generated as a result of G protein activation by a GPCR are directed to endomembranes from the PM. This spatial dislocation of activated G protein molecules uncovers an unanticipated process in cellular regulation mediated by G proteins. As shown in the Chisari et al. (66) , the inactive heterotrimeric G proteins shuttle between the PM and endomembranes. Because heterotrimers are inactive, the shuttling will not have on effect on downstream effectors. The striking effect of 2BP on both shuttling and translocation and the possible diffusion-dependent movement in both cases suggests that the shuttling process is harnessed for receptor-mediated translocation of ␤␥ subunits. Thus, inactive heterotrimer shuttling is converted to the translocation of a potentially active ␤␥ complex to specific endomembranes at different rates.
Two broad roles for the translocation of ␤␥ subunits can be hypothesized. One possibility is that the translocation will reduce the ␤␥ available to act on effectors and to support receptor activation of an ␣ subunit. We predicted that the ␥ subtype constitution of a cell type can, thus, regulate signal amplification in a cell (13) . Consistent with this prediction, a recent report shows that translocation of ␤␥ 1 , which is specific to rod 
TABLE 1
Interaction between G protein ␤ subunits and translocating ␥ subunits (n > 4) Cotransl, cotranslocation; ND, not determined.
Cotransl FRET Cotransl FRET Cotransl FRET Cotransl FRET
photoreceptors, helps photoreceptors adapt to light by reducing the G t available for activation by rhodopsin (50) . The mechanisms at the basis of the translocation are, however, quite distinct from the translocation detected here. The translocation of ␥ 1 occurs along with the ␣ t rod subunit, is comparatively very slow (t1 ⁄ 2 ), and has been shown to be dependent on the nature of the prenyl moiety. Translocation occurs only when the ␥ 1 subunit is modified with farnesyl but not when it is modified with geranylgeranyl. A related possibility is that ␤␥ translocation can regulate unwanted cross-talk. In a variety of cell types, G protein activation leads to activation of a G␣-mediated pathway but not the ␤␥-mediated pathway. In heart cells Gs activates adenylyl cyclase (through the ␣ s subunit) but not K ϩ channels, although ␤␥ is released and is known to be capable of acting on the channel (51) . A second potential function for the translocated ␤␥ subunits is regulation of unknown effectors in the Golgi or ER. Recent reports show that Ras isoforms are present in endomembranes and are capable of getting activated at that location (52) . There is extensive evidence of biologically significant cross-talk between GPCR and receptor-tyrosine kinasemediated pathways (53) . It is known that one mechanism for the activation of Ras and MAPK by the G proteins is through the ␤␥ complex (54) . Although there are suggestions that ␤␥ regulation of Ras activity may occur through transactivation of a receptor-tyrosine kinase (55) or through direct action on Ras through Ras guanine nucleotide exchange factors (56) , the mechanisms at the basis of GPCR and receptor-tyrosine kinase pathways is still unclear, especially in intact cells. The GPCRmediated translocation of a variety of ␤␥ complexes to endomembranes provides a mechanism for regulating Ras activity directly or indirectly. Additionally and importantly, the translocated ␤␥ may act on proteins that regulate trafficking of proteins through the endomembrane system. G protein subunits have been shown to be associated with the Golgi complex, and evidence has been presented to show that they are capable of regulating trafficking of proteins through the Golgi (57-62), but there has been little direct evidence indicating that these functions are executed in a regulated manner (61) . It has not been clear whether the G protein subunits identified remain transiently in the endomembranes on their way to the plasma membrane or are resident proteins of the endomembrane system. Mechanisms that would allow these subunits to associate with endomembranes and function there in a controllable manner have not been found. Such a mechanism is provided by the constant testing of the surfaces of the PM and intracellular membranes by a G protein (66) , facilitating the translocation of a potentially active ␤␥ complex on receptor stimulation. The large family of ␥ subunits with diverse sequences confers spatiotemporal complexity to this unanticipated signaling mechanism. ␤␥ complexes are targeted differentially to intracellular membranes, ␤␥ 13 predominantly to the ER and the others predominantly to the Golgi. The temporal kinetics of translocation differs; ␤␥ 1 , ␤␥ 9 , ␤␥ 11 , and ␤␥ 13 are rapid, ␤␥ 5 and ␤␥ 10 are slow, and the remaining ␤␥ subunits do not translocate. Although the existence of a large family of mammalian G protein ␥ subunits has been known for a long time (2, 63, 64) , such striking distinctions in properties among members of the family have not previously been identified. The ability to alter a non-translocating subunit to a translocating subunit by directed mutagenesis in a domain previously shown to interact with receptors further emphasizes the importance of the differences in the primary structures. It is also consistent with the high degree of evolutionary conservation of the ␥ subunit-type amino acid sequences (12, 65) . To our knowledge this is the only instance of activation-dependent reversible translocation of a family of proteins between the PM and endomembranes.
